Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/28/21 → 02/4/26 |
Funding
- Mitsubishi Tanabe Pharma Corporation: $22,120.00
A Phase 2a, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of MT-3921 in Subjects with Acute Traumatic Cervical Spinal Cord Injury
- Davis, Raphael (PI)
- Chesler, David (CoPI)
- Jawa, Randeep S (CoPI)
- Pendleton, Courtney (CoPI)
- Rubano, Jerry (CoPI)
Project: Research